Otizm Spektrum Bozukluğu ve Epilepsi
Özet
Bu bölümde, Otizm Spektrum Bozukluğu (OSB) ve epilepsi birlikteliği incelenmektedir. Epilepsi, anormal nöronal deşarjlar sonucunda oluşan ve tekrarlayan nöbetlerin görüldüğü sık rastlanan nörolojik bir hastalıktır. OSB ise sosyal iletişimde bozulma ve tekrarlayıcı davranışlarla karakterize olan nörogelişimsel bozukluktur. Bölüm, her iki durumun prevalansı, insidansı ve risk faktörlerini ele alarak, bu durumların birlikteliğinin özellikle entelektüel yetersizlikle ilişkili olarak sık görüldüğünü vurgulamaktadır.Epilepsi prevalansı, genel popülasyonda %1 iken, OSB'li bireylerde %6 ila %30 arasında değişmektedir. Epilepsi gelişimi için üç ana risk faktörü tanımlanmıştır. Bunlar yaş, bilişsel yetenek ve dil bozukluğu derecesidir. OSB'li ergenler ve genç yetişkinlerde epilepsi prevalansı daha yüksektir ve bilişsel yetenek ile epilepsi riski ters orantılıdır. Ayrıca, ağır dil bozuklukları olan hastalar epilepsi açısından daha yüksek risk altındadır. OSB'li hastalarda epilepsi tanısı koymak zordur çünkü semptomlar örtüşebilir ve Elektoensefalografi (EEG) anormallikleri yaygındır. EEG'lerde interiktal epileptiform deşarjlar (IED) sıkça kaydedilir ve bu durum epilepsi tanısını zorlaştırır. OSB'li çocuklarda epilepsi ve EEG anormalliklerinin yaygınlığı, nörobiyolojik temellerin ortak olabileceğini düşündürmektedir. Epilepsi ve OSB'nin birlikte görülmesi, genetik, yapısal ve metabolik faktörlerin rol oynadığı karmaşık bir etiyolojiye işaret eder. Otistik gerileme, OSB'li çocukların %30'unda görülür ve bu durum; dil, davranış ve sosyal iletişim becerilerinin kaybı veya ciddi bozulması olarak tanımlanır. Bu gerileme, bazı epilepsi sendromları ile ilişkilendirilebilir. Epileptik ensefalopati ve sürekli uyku sırasında diken ve dalgalar (EE-CSWS) veya Landau-Kleffner sendromu (LKS) gibi sendromlar, otistik gerileme ile benzerlikler gösterebilir. Ancak, epileptik anormalliklerin ve epilepsinin otistik gerilemeye katkıda bulunup bulunmadığı tartışmalıdır. Bu bölümde ayrıca, OSB ve epilepsi birlikteliğinin klinik uygulamalarda tanı ve tedavi süreçlerini nasıl etkilediğini tartışılmaktadır. Erken tanı ve müdahale, etkilenen bireylerin yaşam kalitesini artırabilir. Klinik uygulamada, OSB'li hastalarda epilepsi tanısı koymak için dikkatli klinik değerlendirme ve EEG kayıtlarının doğru yorumlanması önemlidir. Epilepsi tanısı doğrulandığında, uygun antiepileptik ilaçların seçimi ve tedavi sürecinin yönetimi kritik öneme sahiptir. Sonuç olarak, OSB ve epilepsi birlikteliği, karmaşık ve çok yönlü bir ilişkiye sahiptir. Bu iki durumun birlikte görülmesi, nörogelişimsel ve nörolojik bozuklukların anlaşılmasında önemli ipuçları sunar. Bu birlikteliğin altında yatan mekanizmaları daha iyi anlamak ve daha etkili tedavi yöntemleri geliştirmek için ileri çalışmalara ihtiyaç vardır.
This section examines the co-occurrence of Autism Spectrum Disorder (ASD) and epilepsy. Epilepsy is a common neurological disorder characterized by abnormal neuronal discharges leading to recurrent seizures. ASD, on the other hand, is a neurodevelopmental disorder defined by impairments in social communication and the presence of repetitive behaviors. The chapter discusses the prevalence, incidence, and risk factors of both conditions, emphasizing that their comorbidity is particularly frequent in individuals with intellectual disability. While the prevalence of epilepsy in the general population is approximately 1%, it ranges between 6% and 30% in individuals with ASD. Three major risk factors have been identified for the development of epilepsy in ASD: age, cognitive ability, and degree of language impairment. Adolescents and young adults with ASD exhibit a higher prevalence of epilepsy, and cognitive ability is inversely correlated with epilepsy risk. Additionally, patients with severe language impairments are at greater risk of developing epilepsy. Diagnosing epilepsy in ASD patients is challenging due to overlapping symptoms and the frequent presence of electroencephalographic (EEG) abnormalities. Interictal epileptiform discharges (IEDs) are commonly recorded in EEGs, complicating the diagnostic process. The high prevalence of epilepsy and EEG abnormalities in children with ASD suggests shared neurobiological mechanisms. The co-occurrence of epilepsy and ASD points to a complex etiology involving genetic, structural, and metabolic factors. Autistic regression occurs in approximately 30% of children with ASD and is defined as the loss or severe deterioration of language, behavior, and social communication skills. This regression may be associated with certain epilepsy syndromes, such as epileptic encephalopathy with continuous spike-and-wave during sleep (CSWS) or Landau-Kleffner syndrome (LKS), which share similarities with autistic regression. However, whether epileptic abnormalities and epilepsy contribute to autistic regression remains controversial. This section also discusses how the ASD-epilepsy comorbidity influences diagnostic and therapeutic approaches in clinical practice. Early diagnosis and intervention can significantly improve the quality of life for affected individuals. In clinical settings, a careful evaluation of symptoms and accurate interpretation of EEG recordings are essential for diagnosing epilepsy in ASD patients. Once epilepsy is confirmed, the selection of appropriate antiepileptic drugs (AEDs) and treatment management are critical. In conclusion, the relationship between ASD and epilepsy is complex and multifaceted. The co-occurrence of these conditions provides important insights into the understanding of neurodevelopmental and neurological disorders. Further research is needed to better elucidate the underlying mechanisms and develop more effective treatment strategies.
Referanslar
Fisher, R.S.,Boas, W.V.E., Blume, W., Elger, C., Genton, P., Lee, P., et al., Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia, 2005. 46(4): p. 470-472.
Fisher, R.S., Acevedo, C., Arzimanoglou, A., Bogacz, A., Cross, J.H., Elger, C.E., et al., ILAE official report: a practical clinical definition of epilepsy. Epilepsia, 2014. 55(4): p. 475-482.
Hauser, W.A., Epidemiology of epilepsy in children. Neurosurgery clinics of North America, 1995. 6(3): p. 419-430.
SN, Y., Epilepsi insidansı, prevalansı ve risk faktörleri In: Epilepsi. Eds: Bora İ. Yeni SN. Gürses C. Nobel Tıp Kitabevleri. İstanbul, 2008: p. 65-72.
Maenner, M.J., Prevalence and characteristics of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, United States, 2018. MMWR. Surveillance Summaries, 2021. 70.
Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ, 2012. 61(3): p. 1-19.
Deshmukh, V., Mohapatra, A., Gulati, S., Nair, M., Bhutani, VK., Silberberg, D.H. Prevalence of neuro-developmental disorders in India. in Proceedings of International Meeting for Autism Research. 2013.
Baio, J., Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators; Centers for Disease Control and Prevention (CDC). Prevalence of autism spectrum disorder among children aged 8 years—Autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill Summ, 2014. 63(2): p. 1-21.
Lukmanji, S.,Manji, Sofiya A., Kadhim, S., Sauro, K.M., Wirrell, E.C., Kwon, C.S., et al., The co-occurrence of epilepsy and autism: A systematic review. Epilepsy & Behavior, 2019. 98: p. 238-248.
Berg, A.T. and S. Plioplys, Epilepsy and autism: is there a special relationship? Epilepsy & Behavior, 2012. 23(3): p. 193-198.
Holder Jr, J.L., F.F. Hamdan, and J.L. Michaud, SYNGAP1-related intellectual disability. 2019.
Bozzi, Y., G. Provenzano, and S. Casarosa, Neurobiological bases of autism–epilepsy comorbidity: a focus on excitation/inhibition imbalance. European Journal of Neuroscience, 2018. 47(6): p. 534-548.
Lee, B.H., T. Smith, and A.R. Paciorkowski, Autism spectrum disorder and epilepsy: Disorders with a shared biology. Epilepsy & Behavior, 2015. 47: p. 191-201.
Specchio, N.,Pietrafusa, N., Trivisano, M., Moavero, R., De Palma, L., Ferretti, A., et al., Autism and epilepsy in patients with tuberous sclerosis complex. Frontiers in Neurology, 2020. 11: p. 639.
Tuchman, R. What is the relationship between autism spectrum disorders and epilepsy? in Seminars in pediatric neurology. 2017. Elsevier.
Dawson, G., Rogers, S., Munson, J., Smith, M., Winter, J., Greenson, J., et al., Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model. Pediatrics, 2010. 125(1): p. e17-e23.
McCue, L.M., Flick, L.H., Twyman, K.A., Xian, H., Conturo, T.E., Prevalence of non-febrile seizures in children with idiopathic autism spectrum disorder and their unaffected siblings: a retrospective cohort study. BMC neurology, 2016. 16: p. 1-9.
Amiet, C., Gourfinkel-An, I., Bouzamondo, A., Tordjman, S., Baulac, M., Lechat, P., et al., Epilepsy in autism is associated with intellectual disability and gender: evidence from a meta-analysis. Biological psychiatry, 2008. 64(7): p. 577-582.
Tuchman, R. and I. Rapin, Epilepsy in autism. The Lancet Neurology, 2002. 1(6): p. 352-358.
Viscidi, E.W., Triche, E.W., Pescosolido, M.F., McLean, R.L., Joseph, R.M., Spence, S.J., et. al., Clinical characteristics of children with autism spectrum disorder and co-occurring epilepsy. PloS one, 2013. 8(7): p. e67797.
Ballaban‐Gil, K. and R. Tuchman, Epilepsy and epileptiform EEG: association with autism and language disorders. Mental retardation and developmental disabilities research reviews, 2000. 6(4): p. 300-308.
Danielsson, S., Gillberg, I.C., Billstedt, E., Gillberg, C., Olsson, I., Epilepsy in young adults with autism: a prospective population‐based follow‐up study of 120 individuals diagnosed in childhood. Epilepsia, 2005. 46(6): p. 918-923.
Blackmon K., Bluvstein J., MacAllister W.S., Avallone, J., Misajon, J., Hedlund, J., et. al. treatment resistant epilepsy in autism spectrum disorder: increased risk for females. Autism Res 2016;9(2): 311–20
Thomas, S., Hovinga, M.E., Rai, D., Lee, B.K., Brief report: prevalence of co-occurring epilepsy and autism spectrum disorder: the US National Survey of Children’s Health 2011–2012. Journal of autism and developmental disorders, 2017. 47: p. 224-229.
Su, C.-C., Chi, M.H., Lin, S.H., Yang, Y.K., Bidirectional association between autism spectrum disorder and epilepsy in child and adolescent patients: a population-based cohort study. European child & adolescent psychiatry, 2016. 25: p. 979-987.
H., H., Autism and epilepsy: a retrospective follow-up study. Brain and Development, 2007. 29(8): p. 486-90.
Kanner, L., Autistic disturbances of affective contact. Nervous child, 1943. 2(3): p. 217-250.
Tuchman, R., M. Cuccaro, and M. Alessandri, Autism and epilepsy: historical perspective. Brain and Development, 2010. 32(9): p. 709-718.
Ghacibeh, G.A. and C. Fields, Interictal epileptiform activity and autism. Epilepsy & Behavior, 2015. 47: p. 158-162.
Spence, S.J. and M.T. Schneider, The role of epilepsy and epileptiform EEGs in autism spectrum disorders. Pediatric research, 2009. 65(6): p. 599-606.
Tuchman R. Treatment of seizure disorders and EEG abnormalities in children with autism spectrum disorders. J Autism Dev Disord 2000;30:485–489. [PubMed: 11098889]
Peng J, Zhou Y, Wang K. Multiplex gene and phenotype network to characterize shared genetic pathways of epilepsy and autism. Sci Rep 2021;11(1):952
Kanemura, H., Sano, F., Tando, T., Sugita, K., Aihara, M., Can EEG characteristics predict development of epilepsy in autistic children? European Journal of Paediatric Neurology, 2013. 17(3): p. 232-237.
Steffenburg, S., Psychiatric disorders in children and adolescents with active epilepsy and mental retardation. Arch Neurol, 1996. 53: p. 904-912.
Kanemura, H., Sano, F., Ohyama, T., Sugita, K., Aihara, M., Effect of levetiracetam on behavioral problems in pervasive developmental disorder children with epilepsy. european journal of paediatric neurology, 2014. 18(4): p. 482-488.
Rossi, P.G., Parmeggiani, A., Bach, V., Santucci, M., Visconti, P., EEG features and epilepsy in patients with autism. Brain and Development, 1995. 17(3): p. 169-174.
Akshoomoff, N., Farid, N., Courchesne, E., Haas, R., Abnormalities on the neurological examination and EEG in young children with pervasive developmental disorders. Journal of autism and developmental disorders, 2007. 37: p. 887-893.
Chez, M.G., et al., Frequency of epileptiform EEG abnormalities in a sequential screening of autistic patients with no known clinical epilepsy from 1996 to 2005. Epilepsy & Behavior, 2006. 8(1): p. 267-271.
Kim, H.L., Donnelly, J.H., Tournay, A.E., Book, T.M., Filipek, P., Absence of seizures despite high prevalence of epileptiform EEG abnormalities in children with autism monitored in a tertiary care center. Epilepsia, 2006. 47(2): p. 394-398.
García-Peñas JJ. Autismo, epilepsia y patología del lóbulo temporal [Autism, epilepsy and temporal lobe pathology]. Rev Neurol. 2009 Feb 27;48 Suppl 2:S35-45. Spanish. PMID: 19280573.
Kanemura, H., Sano, F., Tando, T., Sugita, K., Aihara, M., Repeated seizures induce prefrontal growth disturbance in frontal lobe epilepsy. Brain and Development, 2012. 34(3): p. 175-180.
Hughes, R., W.-Y. Poon, and A.S. Harvey, Limited role for routine EEG in the assessment of staring in children with autism spectrum disorder. Archives of Disease in Childhood, 2015. 100(1): p. 30-33.
Sanlidag B., Donbaloglu F., Yanartas MS., Sekeroglu B., Yilmaz A., Koken OY., High-frequency oscillations in autism spectrum disorder: are they related to clinical severity? Cerebral Cortex, 2025 https:doi.org/10.1093/cercor/bhaf068
Burack, J.A. and F.R. Volkmar, Development of low‐and high‐functioning autistic children. Journal of Child Psychology and Psychiatry, 1992. 33(3): p. 607-616.
Auvin, S., M.R. Cilio, and A. Vezzani, Current understanding and neurobiology of epileptic encephalopathies. Neurobiology of disease, 2016. 92: p. 72-89.
Desprairies, C., Dozières-Puyravel, B., Ilea, A., Bellavoine, V., Nasser, H., Delanöe, C., et al., Early identification of epileptic encephalopathy with continuous spikes-and-waves during sleep: A case-control study. European Journal of Paediatric Neurology, 2018. 22(5): p. 837-844.
Tuchman, R.F. and I. Rapin, Regression in pervasive developmental disorders: seizures and epileptiform electroencephalogram correlates. Pediatrics, 1997. 99(4): p. 560-566.
Hrdlicka, M., Komarek, V., Propper, L., Kulisek, R., Zumrova, A., Faladova, L., et.al., Not EEG abnormalities but epilepsy is associated with autistic regression and mental functioning in childhood autism. European child & adolescent psychiatry, 2004. 13: p. 209-213.
Dash, D., Sharma, A., Yuvraj, K., Renjith, A., Mehta, S., Vasantha, P.M., et al., Can home video facilitate diagnosis of epilepsy type in a developing country? Epilepsy Research, 2016. 125: p. 19-23.
Auvin, S., Management of childhood epilepsy. Presse Medicale (Paris, France: 1983), 2011. 40(3): p. 287-292.
Douglas, J.F., Sanders, K.B., Benneyworth, M.H., Smith, J.L. DeJean, V.M., McGrew, S.G., et al., Brief report: retrospective case series of oxcarbazepine for irritability/agitation symptoms in autism spectrum disorder. Journal of autism and developmental disorders, 2013. 43: p. 1243-1247.
Frye, R.E., S. Sreenivasula, and J.B. Adams, Traditional and non-traditional treatments for autism spectrum disorder with seizures: an on-line survey. BMC pediatrics, 2011. 11: p. 1-18.
Hirota, T., Veenstra-VanderWeele, J., Hollander, E., Kishi, T., Antiepileptic medications in autism spectrum disorder: a systematic review and meta-analysis. Journal of autism and developmental disorders, 2014. 44: p. 948-957.
Eddy, C.M., H.E. Rickards, and A.E. Cavanna, The cognitive impact of antiepileptic drugs. Therapeutic advances in neurological disorders, 2011. 4(6): p. 385-407.
